MENAFN - 11:47查看原文
Biomednewsbreaks - Inmed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results For INM-901 In Alzheimer's Neuroinflammation Model
InMed Pharmaceuticals (NASDAQ: INM) , a pharmaceutical company developing small molecule drug candidates for diseases with high unmet medical needs,